Dr. Stuart Kevin Amateau, MD, PhD

Dr. Amateau practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Amateau's NPI, 1083769855, was assigned on January 24, 2007. Dr. Amateau graduated from University of Maryland School of Medicine in 2005. Dr. Amateau holds Minnesota license 57684.

Dr. Amateau's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Amateau's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Amateau is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Amateau to 3 more hospitals, 4 medical groups, 3 group practices and clinics, 1 dialysis center and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amateau practices, 10 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Amateau's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Amateau is licensed in Minnesota.

Dmand AI lists acid reflux, colonoscopy, intestinal or bowel obstruction, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Amateau treats.

CMS data shows 269 Medicare services from Dr. Amateau across 10 procedure codes in 2024, for 132 Medicare patients. Medicare paid $33,479 for them.

CMS counts 132 Medicare patients who saw Dr. Amateau in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 59% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amateau's median patient age at 66, with 65% women.

In 2024, Dr. Amateau wrote 174 Medicare Part D claims for 90 patients. 73% of them were for generic drugs. CMS names the drug for 117 of them, across 7 drugs with 11 or more claims each, at $111,134 in total drug cost. In 2023, CMS named 79 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Amateau for performance year 2024, reported as part of a group. Dr. Amateau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amateau as offering telehealth. CMS counts 230 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Amateau, more than 92% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 115 papers to Dr. Amateau, published from 2010 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Endoscopy, Gastrointestinal, Stents and Endosonography. Dr. Amateau has published most often in Gastrointest Endosc. Dr. Amateau's most frequent co-authors are Martin L. Freeman, MD, Divyanshoo Rai Kohli, MD and Bashar Jeryes Qumseya, MD, MPH.

CMS Open Payments shows 237 general payments to Dr. Amateau from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Boston Scientific Corporation paid the most, $50,289.

Dmand AI lists 1 award for Dr. Amateau, most recently CMS Stage 1 EHR in 2013.

Dr. Amateau graduated from University of Maryland School of Medicine in 2005.

Dr. Amateau is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.